(AP) -- Swiss pharmaceutical giant Roche announced Tuesday a 7 percent rise in its first-half sales to SFr13.4 billion ($ 8.5 billion).This content was published on July 13, 1999 - 10:06
(AP) -- Swiss pharmaceutical giant Roche announced Tuesday a 7 percent rise in its first-half sales to SFr13.4 billion ($8.5 billion).
Roche said it expects "barring extraordinary events, another good result" for the full year following the sales figure, up from SFr12.53 billion ($7.9 billion) in the first half of 1998.
First-half profits, which will be announced at a later date, should be up from a year ago, the company said.
But those expectations exclude special charges related to its involvement in a vitamins price-fixing scheme, the company said.
In May, the U.S. Justice Department said Roche and BASF AG of Germany had agreed to plead guilty and pay a record $725 million criminal fine for engaging in a worldwide conspiracy to raise and fix the prices of vitamins. Roche's share was $500 million.
The forecast also excludes the results of Roche's agreement to buy outstanding shares of U.S. biotech firm Genentech Inc. and then make a public offering to sell around 17 percent of the shares,
In March, Roche said its profits for 1998 were up 3 percent on the previous year at SFr4.39 ($2.8 billion).
This article was automatically imported from our old content management system. If you see any display errors, please let us know: firstname.lastname@example.org